SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

7754 (7754) News

Follow 7754 (7754) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 7754 Asset market Sector Markets 90 days 1 Updated Sep 03, 2026, 07:59 AM UTC Open live news feed
M AnnJi files U.S. FDA application for Phase 3 AJ201 trial AnnJi Pharmaceutical Co Ltd has submitted an application to the U.S. FDA for a Phase 3 clinical trial of AJ201. REGULATION | Sep 03, 2026, 07:59 AM UTC